In univariate analysis, age, menopausal status, histologic grade, tumor size, hormone receptor statuses, HER2 status, pN stages and LODDS were associated with cancer-specific survival of breast cancer patients (Table 2, all p < 0.05). This evidence concerns the gene ERBB2 and cancer.